New Monoclonal Antibody Prevents RSV in Infants and Toddlers

• 2023

  Log in to bookmark this resource.

  Log in
• Diane Aschenbrenner
PMID: 37732664DOI: https://dx.doi.org/10.1097/01.NAJ.0000979076.37269.a5

---

Access Resources

• Journal ArticleEN
• Ask aRCie About This Resource

About

This article discusses the approval of the monoclonal antibody nirsevimab-alip (Beyfortus) to prevent respiratory syncytial virus (RSV) in high-risk neonates and infants up to 24 months old. It emphasizes that this antibody, given via injection at the start of the RSV season, helps reduce the risk of severe RSV symptoms. The safety and effectiveness of nirsevimab-alip were supported by three clinical trials, showing a decrease in medically attended RSV lower respiratory tract infections. However, caution is advised due to potential serious hypersensitivity reactions. This development is significant for vulnerable children at risk of severe RSV disease.

---

Tags

Focus Area: Infectious Disease

Audiences: Nurses; Physicians

Emergency Management Stage: Preparedness (Prevention / Protection)

Bundles: Nirsevimab Library

Keywords: Antibodies, Monoclonal; Child, Preschool; Infant; Respiratory Syncytial Viruses; Virus Diseases; Respiratory Syncytial Virus Vaccines

Institutions: Johns Hopkins School of Nursing; Johns Hopkins University

---

More like this

Caring for Children After a Radiological Disaster 2015 · Johns Hopkins School of Nursing, Johns Hopkins University Ethical Obligations Regarding Short-Term Global Health Clinical Experiences: An American College of Physicians Position Paper 2018 · Johns Hopkins University, National Center for Ethics in Health Care, U.S. Department of Veterans Affairs, University of California –San Diego School of Medicine, University of California, San Diego, Virginia Mason Medical Center Severe Pediatric Neurological Manifestations With SARS-CoV-2 or MIS-C Hospitalization and New Morbidity 2024 · Montreal Children's Hospital, Children's Hospital of Philadelphia, University of Pennsylvania, Johns Hopkins University, Seattle Children's Hospital, Universidad Nacional de Colombia, Fundación Universitaria de Ciencias de la Salud, Nationwide Children's Hospital

---

The information provided on this website is for educational purposes only. It does not substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

---